1. Home
  2. News

SFDA Issues IECIC Third Batch (draft)

  •   18 Sep 2012
  •    Echo Cao
  •  2915
  •   Post a comment

    China SFDA releases the third batch (draft) of the Inventory of Existing Cosmetic Ingredient in China (IECIC) for public consultation following the issuance of first and second batch earlier this year. You are invited to make comments on it before September 30, 2012.

    There are 1356 ingredients in the third batch, which are regarded as “assessed” and can be used to make cosmetics directly on the basis of complying with maximum use limit and requirements in Hygienic Standard for Cosmetics (2007). Officials from SFDA said that there are only three batches with 3667 cosmetic ingredients included, but it is still not sure when they will be consolidated and officially put into force. 

    In China, a new cosmetic ingredient must be licensed with SFDA prior to use. As a key reference for judging whether an ingredient is new or not, IECIC 2003 published by Ministry of Health (MoH) cannot meet the growing demand of safety and quality of cosmetics. Therefore, since SFDA took over the responsibility of cosmetics control from MoH in 2008, it has been dedicated to revise and improve the inventory to facilitate the administrative licensing of cosmetic new ingredients.

    Chemlinked provides bilingual text of three batches for free download below. 

    The comparison between IECIC 2003 and 2012

    IECIC (2003)

    2003-04-27

    IECIC (2012)

    2012-04-27+2012-06-28+2012-09-17

    • 3265 cosmetic ingredients in total.
    • 2156 general ingredients;
    • 546 specific cosmetic ingredients;
    • 563 natural ingredients 
    • Only including the INCI name, Chinese name and CAS number
    • first batch: 1674 cosmetic ingredients
    • second batch: 637 cosmetic ingredients
    • third batch: 1356 cosmetic ingredients
    • indicating both the name and the authorized maximum use limit and specified limit of use in Hygienic Standard for Cosmetic (2007)

    Preview of the third batch

    The Inventory of Existing Cosmetic Ingredient in China (IECIC)  (third Batch)

    ( opinion-soliciting draft)

    已使用化妆品原料名称目录(第三批)

    征求意见稿

    Order nr.

    序号

    Chinese name

    中文名

    INCI name

    INCI

    Limit of use使用限量

    Authorized Maximum use limit

    已获批准产品中最高使用量(%)

    Specified limit of use in  Hygienic Standard for Cosmetics (2007)

    《化妆品卫生规范》(2007年版)规定使用限量

    Maximum concentration permitted in cosmetics

    化妆品中最大允许使用浓度(%)

    Other restrictions and requirements 其它限制和要求

    1

    (动物)胸腺提取物

    THYMUS EXTRACT

    12

     

     

    2

    1-(3,4-二甲氧基苯基)-4,4-二甲基-1,3-戊二酮

     

    1

     

     

    3

    1,3-双-(2,4-二氨基苯氧基)丙烷

    1,3-BIS-(2,4-DIAMINOPHENOXY)PROPANE

    0.4

     

     

    4

    1-萘酚(CI 76605)

    1-NAPHTHOL(CI 76605)

     

    1

     

     

    5

    2,4-二氨基苯酚

    2,4-DIAMINOPHENOL

    0.1

     

     

    6

    2,4-二氨基苯氧基乙醇

     

    0.35

     

     

    7

    2,6-双(2-羟乙氧基)-3,5-吡啶二胺 HCL

    2,6-BIS(2-HYDROXYETHOXY)-3,5-PYRIDINEDIAMINE HCL

    0.006

     

     

    8

    27.5% 过氧化氢

     

    22.5

     

     

    9

    2-氨基-4-羟乙氨基茴香醚

    2-AMINO-4-HYDROXYETHYLAMINOANISOLE

    0.0006

    3

    When used in mixtures with oxidized milk,maximum concentration is 1.5%

    当与氧化乳混合使用时, 最大使用浓度应为1.5%

    Reference Links

     Inventory of Existing Cosmetic Ingredient in China (IECIC)

     Hygienic Standard for Cosmetics (2007)

    You are a visitor, Please login.

    Share this:

    ABOUT THE AUTHOR

    ChemLinked Editor

    COPYRIGHT: You may circulate web links to the web and contents, but they are intended for your personal, non-commercial use only. For other use of any materials, you can contact with cleditor@reach24h.com to seek consent. Find out more about our copyright policy here.
    CORRECTIONS: we do our best to provide you with accurate information. However sometimes errors slip under the radar. If you notice any errors contact us on: cleditor@reach24h.com
    Content sharing or co-authoring: just send messages to our editor team.